Coronavirus (COVID-19)

An easy weekly spray up the nose has become a contender for being a first-in-class treatment for protection from respiratory viruses, including the flu. And the startup advancing this breakthrough is heavily backed by the US Department of Defense.

In somewhat of a surprise announcement, the Food and Drug Administration has approved the first US influenza vaccine engineered from the mRNA technology that gave us one of the most administered COVID-19 shots during the pandemic.